Works matching Fox Chase Cancer Center

Results: 4360
    1
    2

    Corrigendum: Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic

    Published in:
    2021
    By:
    • Ghatalia, Pooja;
    • Smith, Chad H.;
    • Winer, Arthur;
    • Gou, Jiangtao;
    • Kiedrowski, Lesli A.;
    • Slifker, Michael;
    • Saltzberg, Patricia D.;
    • Bubes, Nicole;
    • Anari, Fern M.;
    • Kasireddy, Vineela;
    • Varshavsky, Asya;
    • Liu, Yang;
    • Ross, Eric A.;
    • El-Deiry, Wafik S.
    Publication type:
    Correction Notice
    3
    4
    5
    6
    7

    Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic

    Published in:
    Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2018.00652
    By:
    • Ghatalia, Pooja;
    • Smith, Chad H.;
    • Winer, Arthur;
    • Gou, Jiangtao;
    • Kiedrowski, Lesli A.;
    • Slifker, Michael;
    • Saltzberg, Patricia D.;
    • Bubes, Nicole;
    • Anari, Fern M.;
    • Kasireddy, Vineela;
    • Varshavsky, Asya;
    • Liu, Yang;
    • Ross, Eric A.;
    • El-Deiry, Wafik S.
    Publication type:
    Article
    8
    9
    10
    11

    Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma(The following member institutions participated in the current study: Abington Memorial Hospital (Abington, Pennsylvania); Colorado Gynecologic Oncology Group P.C. (Denver, Colorado); University of California–Los Angeles (Los Angeles, California); University of Pennsylvania Cancer Center (Philadelphia, Pennsylvania); University of North Carolina School of Medicine (Chapel Hill, North Carolina); University of Iowa Hospitals and Clinics (Iowa City, Iowa); University of Texas Southwestern Medical Center at Dallas (Dallas, Texas); Indiana University Medical Center (Indianapolis, Indiana); Wake Forest University School of Medicine (Winston-Salem, North Carolina); State University of New York at Stony Brook (Stony Brook, New York); Cooper Hospital/University Medical Center (Camden, New Jersey); Columbus Cancer Council (Columbus, Ohio); Fox Chase Cancer Center)

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 8, p. 1664, doi. 10.1002/cncr.11690
    By:
    • David Scott Miller;
    • John A. Blessing;
    • Samuel S. Lentz;
    • D. Scott McMeekin
    Publication type:
    Article
    12

    Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older<FN ID="fn1">The following are the Clinical Staff of the Breast Evaluation Center at the Fox Chase Cancer Center. Department of Medical Oncology: Lori J. Goldstein, M.D. (Director), Michael M. Millenson, M.D., Mary E. Cianfrocca, D.O., and Margaret von Mehren, M.D.; Department of Radiation Oncology: Gary M. Freedman, M.D. (Associate Director), Penny R. Anderson, M.D., and Nicos Nicolaou, M.D.; Department of Surgical Oncology: Marcia C. Boraas, M.D., F.A.C.S., Michael H. Torosian, M.D., Elin R. Sigurdson, M.D., Ph.D., and John P. Hoffman, M.D., F.A.C.S.; Department of Diagnostic Imaging: Kathryn Evers, M.D. and Arthur D. Magilner, M.D.; and Department of Pathology: Arthur S. Patchefsky, M.D., Harry S. Cooper, M.D., Tahseen I. Al-Saleem, M.D., Hormoz Ehya, M.D., Nancy A. Young, M.D., and Hong Wu, M.D., Ph.</FN>

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 5, p. 918
    By:
    • Gary M. Freedman;
    • Penny R. Anderson;
    • Lori J. Goldstein;
    • Alexandra L. Hanlon;
    • Mary E. Cianfrocca;
    • Michael M. Millenson;
    • Margaret von Mehren;
    • Michael H. Torosian;
    • Marsha C. Boraas;
    • Nicos Nicolaou;
    • Arthur S. Patchefsky;
    • Kathryn Evers
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Editor's Comment.

    Published in:
    BJU International, 2011, v. 107, n. 2, p. i, doi. 10.1111/j.1464-410X.2010.10066.x
    By:
    • Fitzpatrick, John M.
    Publication type:
    Article
    30
    31
    32

    Genetics: Written in blood.

    Published in:
    Nature, 2013, v. 498, n. 7455, p. S4, doi. 10.1038/498S4a
    By:
    • DeWeerdt, Sarah
    Publication type:
    Article
    33
    34
    35
    36

    ABSTRACTS.

    Published in:
    2004
    Publication type:
    Abstract
    37
    38

    Population cancer screening.

    Published in:
    1976
    By:
    • Sutnick, Alton I.;
    • Miller, Daniel G.;
    • Samson, Bien;
    • Dean, Donna H.;
    • Kukowski, Kathleen M.;
    • Halpern, Leslie;
    • Jefferys, Catherine;
    • Bahn, Anita K.;
    • Sutnick, A I;
    • Miller, D G;
    • Samson, B;
    • Dean, D H;
    • Kukowski, K M;
    • Halpern, L;
    • Jefferys, C;
    • Bahn, A K
    Publication type:
    journal article
    39

    Here I Am, Despite Myself.

    Published in:
    PLoS Pathogens, 2015, v. 11, n. 9, p. 1, doi. 10.1371/journal.ppat.1005106
    By:
    • Rall, Glenn
    Publication type:
    Article
    40
    41
    42

    News Update.

    Published in:
    Urology Times, 2008, v. 36, n. 2, p. 6
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Irma H. Russo, MD.

    Published in:
    Hormone Molecular Biology & Clinical Investigation, 2013, v. 16, n. 3, p. 115, doi. 10.1515/hmbci-2013-0045
    By:
    • Russo, Jose
    Publication type:
    Article
    50